Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF ) Freely available
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (9)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Loras, B.
Right arrow Articles by Benahmed, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Loras, B.
Right arrow Articles by Benahmed, M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Reproduction, Vol. 14, No. 6, 1534-1539, June 1999
© 1999 European Society of Human Reproduction and Embryology

Seminal transforming growth factor-ß in normal and infertile men

Bernadette Loras1, Florence Vételé1, Ahmed El Malki1, Jacques Rollet2, Jean-Claude Soufir3 and Mohamed Benahmed1,4

1 Institut National de la Santé et de la Recherche Médicale, INSERM U407, Faculté de Médecine Lyon-Sud, B.P. 12, F-69961 Oullins cedex, 2 Institut Rhône-Alpin, F-69400 Bron and 3 Laboratoire de Biologie Andrologique, CHU Bicêtre, F-94275 Le Kremlin-Bicêtre, France

Transforming growth factor-ß (TGFß) is a cytokine with autocrine and paracrine action in the testis and potent immunoregulatory and anti-inflammatory activities. In the present study, we examined the concentration of latent (acid-activatable) and free (active) TGFß in seminal plasma from normal subjects (n = 23) and infertile (n = 40) patients, by using a TGFß specific immunoenzymological assay, and a bioassay (CCL64 cell line growth inhibition) detecting any form of TGFß. Free TGFß1 was present in normal subjects at a concentration (1.82 ± 1.06 ng/ml) close to that known to give maximal stimulation in vitro. In pathological groups, the mean concentrations were not significantly different from the normal ones. Latent TGFß1 was present in normal seminal plasma at a high concentration (92.4 ± 29.2 ng/ml). In subjects with pathologies of both testis and genital apparatus, or with epididymal occlusion, mean latent TGFß1 concentrations were normal, whereas transferrin concentrations were lower. The concentrations found in the epididymal occlusion group indicate that TGFß1 is, for a large part, secreted by the genital tract. In the testicular pathology group, TGFß1 concentrations were 130.7 ± 61.2 ng/ml, a mean not statistically different from normal, although higher. No differences were found between patients with high and normal blood plasma follicle stimulating hormone, and this is consistent with the notion that most TGFß1 in seminal plasma is not of testicular origin. The TGFß bioassay ensured that immunologically detected TGFß was present in a bioactive or bioactivatable form. Furthermore, the values found in normal and pathological seminal plasmas were usually higher than those detected by the immunoassay, suggesting that other forms of TGFß might be present. Together, the present data show that very large amounts of TGFß are present in human seminal plasma. The TGFß ligand assay in the seminal plasma appears to indicate no differences between normal and infertile subjects.

Key words: human/infertility/seminal plasma/TGFß

4 To whom correspondence should be addressed


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Hum ReprodHome page
J. A. Politch, L. Tucker, F. P. Bowman, and D. J. Anderson
Concentrations and significance of cytokines and other immunologic factors in semen of healthy fertile men
Hum. Reprod., November 1, 2007; 22(11): 2928 - 2935.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. K. O'Bryan, O. Gerdprasert, D. J. Nikolic-Paterson, A. Meinhardt, J. A. Muir, L. M. Foulds, D. J. Phillips, D. M. de Kretser, and M. P. Hedger
Cytokine profiles in the testes of rats treated with lipopolysaccharide reveal localized suppression of inflammatory responses
Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2005; 288(6): R1744 - R1755.
[Abstract] [Full Text] [PDF]


Home page
J AndrolHome page
S. Basu, T. C. Aballa, S. M. Ferrell, C. M. Lynne, and N. L. Brackett
Inflammatory Cytokine Concentrations Are Elevated in Seminal Plasma of Men With Spinal Cord Injuries
J Androl, March 1, 2004; 25(2): 250 - 254.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
S. Gutsche, M. von Wolff, T. Strowitzki, and C.J. Thaler
Seminal plasma induces mRNA expression of IL-1{beta}, IL-6 and LIF in endometrial epithelial cells in vitro
Mol. Hum. Reprod., December 1, 2003; 9(12): 785 - 791.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.